APA

Black K. J., Nasrallah H., Isaacson S., Stacy M., Pahwa R., Adler C. H., Alva G., Cooney J. W., Kremens D., Menza M. A., Meyer J. M., Patkar A. A., Simuni T., Morrissette D. A. & Stahl S. M. (102019). Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. : CNS spectrums.

Chicago

Black Kevin J, Nasrallah Henry, Isaacson Stuart, Stacy Mark, Pahwa Rajesh, Adler Charles H, Alva Gustavo, Cooney Jeffrey W, Kremens Daniel, Menza Matthew A, Meyer Johnathan M, Patkar Ashwin A, Simuni Tanya, Morrissette Debbi A and Stahl Stephen M. 102019. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. : CNS spectrums.

Harvard

Black K. J., Nasrallah H., Isaacson S., Stacy M., Pahwa R., Adler C. H., Alva G., Cooney J. W., Kremens D., Menza M. A., Meyer J. M., Patkar A. A., Simuni T., Morrissette D. A. and Stahl S. M. (102019). Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. : CNS spectrums.

MLA

Black Kevin J, Nasrallah Henry, Isaacson Stuart, Stacy Mark, Pahwa Rajesh, Adler Charles H, Alva Gustavo, Cooney Jeffrey W, Kremens Daniel, Menza Matthew A, Meyer Johnathan M, Patkar Ashwin A, Simuni Tanya, Morrissette Debbi A and Stahl Stephen M. Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. : CNS spectrums. 102019.